Literature DB >> 15030124

Severe thrombocytopenia as a complication of acute Epstein-Barr virus infection.

Robert Likic1, Dusko Kuzmanic.   

Abstract

Severe thrombocytopenia is an extremely rare complication of acute Epstein-Barr virus (EBV) infection. EBV infection usually causes hematological abnormalities, mainly atypical lymphocytosis, which is a feature of infectious mononucleosis, and uncomplicated cases often present with mild decreases in platelet counts. Our otherwise healthy, 21-year-old male Caucasian patient had thrombocytopenia and bleeding diathesis with platelet counts of 8 x 10(9)/L without other signs and symptoms of infectious mononucleosis. We commenced treatment with intravenous methylprednisolone before the acute EBV infection was serologically confirmed. Platelet counts initially rose and then fell after we stopped administrating corticosteroids. Repeated administration of methylprednisolone was followed by full recovery of the platelet count and normalization of formerly elevated transaminases. EBV infection may happen in children, adolescents and adults and this differential diagnosis should be considered in every patient presenting with acute thrombocytopenia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15030124     DOI: 10.1007/BF03040424

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   2.275


  20 in total

Review 1.  Acute complications of Epstein-Barr virus infectious mononucleosis.

Authors:  H B Jenson
Journal:  Curr Opin Pediatr       Date:  2000-06       Impact factor: 2.856

2.  PLATELET LEVELS IN INFECTIOUS MONONUCLEOSIS.

Authors:  R L CARTER
Journal:  Blood       Date:  1965-05       Impact factor: 22.113

3.  Acyclovir and prednisolone treatment of acute infectious mononucleosis: a multicenter, double-blind, placebo-controlled study.

Authors:  E Tynell; E Aurelius; A Brandell; I Julander; M Wood; Q Y Yao; A Rickinson; B Akerlund; J Andersson
Journal:  J Infect Dis       Date:  1996-08       Impact factor: 5.226

4.  Epstein-Barr virus induced thrombocytopenia treated with intravenous acyclovir and immunoglobulin.

Authors:  H Hugo; A Linde; P E Abom
Journal:  Scand J Infect Dis       Date:  1989

Review 5.  Fatal infectious mononucleosis: a critical review.

Authors:  H G Penman
Journal:  J Clin Pathol       Date:  1970-12       Impact factor: 3.411

6.  Rupture of the spleen in infectious mononucleosis: a critical review.

Authors:  I M Rutkow
Journal:  Arch Surg       Date:  1978-06

7.  Acyclovir treatment in infectious mononucleosis: a clinical and virological study.

Authors:  J Andersson; B Sköldenberg; W Henle; J Giesecke; A Ortqvist; I Julander; E Gustavsson; B Akerlund; S Britton; I Ernberg
Journal:  Infection       Date:  1987       Impact factor: 3.553

8.  Effect of acyclovir on infectious mononucleosis: a double-blind, placebo-controlled study.

Authors:  J Andersson; S Britton; I Ernberg; U Andersson; W Henle; B Sköldenberg; A Tisell
Journal:  J Infect Dis       Date:  1986-02       Impact factor: 5.226

Review 9.  Life-threatening thrombocytopenia associated with acute Epstein-Barr virus infection in an older adult.

Authors:  R B Walter; T C Hong; E B Bachli
Journal:  Ann Hematol       Date:  2002-10-29       Impact factor: 3.673

Review 10.  Acyclovir and Epstein-Barr virus infection.

Authors:  J S Pagano; J W Sixbey; J C Lin
Journal:  J Antimicrob Chemother       Date:  1983-09       Impact factor: 5.790

View more
  7 in total

1.  Severe thrombocytopenia and recurrent epistaxis associated with primary Epstein-Barr virus infection.

Authors:  William Tilden; Shahnawaz Valliani
Journal:  BMJ Case Rep       Date:  2015-04-09

2.  Hunter syndrome with persistent thrombocytopenia.

Authors:  Inusha Panigrahi; Manoj Dhanorkar; Siyaram Didel; Raja Ashok Koganti
Journal:  BMJ Case Rep       Date:  2019-04-20

3.  Comparative study on infection-induced thrombocytopenia among returned travellers.

Authors:  K-H Herbinger; M Schunk; H D Nothdurft; F von Sonnenburg; T Löscher; G Bretzel
Journal:  Infection       Date:  2012-02-17       Impact factor: 3.553

4.  Secondary Immune Thrombocytopenic Purpura Due to Primary Epstein- Barr Virus Infection.

Authors:  Heba Yusuf; Aretha Kou; Claire Zelinskas; Girma Ayele; Johnathan Frunzi; Rediet Tefera Atalay; Miriam B Michael
Journal:  Cureus       Date:  2022-06-20

5.  Perspectives of Phage-Eukaryotic Cell Interactions to Control Epstein-Barr Virus Infections.

Authors:  Andrzej Górski; Ryszard Międzybrodzki; Ewa Jończyk-Matysiak; Beata Weber-Dąbrowska; Natalia Bagińska; Jan Borysowski
Journal:  Front Microbiol       Date:  2018-04-03       Impact factor: 5.640

6.  Chronic Pediatric Immune Thrombocytopenia Is Not Associated With Herpes Virus Infection Status.

Authors:  Tao Li; Gui-Ling Yan; Zhu Luo; Qi Xie; Mei-Mei Lai; Zhan-Guo Chen; Xiao-Qun Zheng
Journal:  Front Pediatr       Date:  2021-12-02       Impact factor: 3.418

7.  Longitudinal multiparametric characterization of platelet dysfunction in COVID-19: Effects of disease severity, anticoagulation therapy and inflammatory status.

Authors:  Alexey A Martyanov; Anna E Boldova; Maria G Stepanyan; Olga I An; Alexander S Gur'ev; Darya V Kassina; Alexey Y Volkov; Alexandr V Balatskiy; Andrei A Butylin; Sergei S Karamzin; Elena V Filimonova; Sergei V Tsarenko; Sergei A Roumiantsev; Alexander G Rumyantsev; Mikhail A Panteleev; Fazoil I Ataullakhanov; Anastasia N Sveshnikova
Journal:  Thromb Res       Date:  2022-01-15       Impact factor: 3.944

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.